Sysmex, a global provider of medical diagnostic testing equipment and information systems technology, has entered into a three-year, dual source urinalysis contract agreement with Amerinet.
As per the agreement, Amerinet members will have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls, and service.
Headquartered in Mundelein, Illinois, Sysmex America provides training and technical support for Amerinet members. The contract which was awarded on technical merit and pricing also includes Sysmex e-Tools, a comprehensive set of systems and resources that support a clinical laboratory’s long-term success before, during and after instrument or system implementation.
Sysmex claimed that it has developed Sysmex UF-100, the first fully automated urine cell analyzer in the world the making its debut in Japan in 1995 and in the US in 1996. Since that time, Sysmex introduced its UF-1000i automated urine particle analyzer.
The Sysmex UF-1000i combines the advanced technology of fluorescent flow cytometry with fully automated urine sample analysis, providing walk away capability and standardization.
John Kershaw, president and CEO of Sysmex America, said: “We at Sysmex America are especially pleased to serve as Amerinet’s partner in supporting their member-laboratories’ needs to automate microscopic urinalysis typically a very time-consuming endeavor when performed manually. We trust that Amerinet members will embrace the reliability and uptime of our instruments as they work to provide high quality, cost-effective patient care in a competitive healthcare environment.”
Amerinet is a national healthcare group purchasing organization that strategically partners with more than 41,000 healthcare providers to reduce costs and improve quality.